Dr. Reddy's Laboratories (RDY) earnings per share (EPS)

Earnings per share · fiscal 2026
₹51.42

Dr. Reddy's Laboratories (RDY) reported diluted earnings per share of ₹51.42 in fiscal 2026 (the year ended March 31, 2026). That is 24.1% lower than the ₹67.79 of fiscal 2025. Figures as of 18 Nov 2026, 01:34 UTC, from Yahoo Finance.

Key facts

Earnings per share, fiscal 2026
₹51.42
Change on fiscal 2025
−24.1%
Highest on record
₹67.79fiscal 2025
Lowest on record
₹51.42fiscal 2026
Fiscal years on record
42023–2026

Figures as of . Statements from Yahoo Finance. Amounts are in INR. Figures, not advice.

Dr. Reddy's Laboratories earnings per share (EPS), in more detail

Across the 4 fiscal years on record (2023–2026), the highest was ₹67.79 in fiscal 2025 and the lowest ₹51.42 in fiscal 2026.

History · 4 fiscal years

Earnings per share by fiscal year

Dr. Reddy's Laboratories earnings per share (EPS), year by year

Dr. Reddy's Laboratories (RDY) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2026₹51.42 24.1% down
2025₹67.79 1.3% up
2024₹66.92 23.5% up
2023₹54.18—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Dr. Reddy's Laboratories and comparable companies
CompanyEarnings per shareFiscal year
Smith & Nephew SNN$1.432025
Penumbra PEN$4.522025
Dr. Reddy's Laboratories RDY₹51.422026
Align Technology ALGN$5.652025
Cooper Companies COO$1.872025
Fresenius Medical Care FMS€1.682025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RDY

Dr. Reddy's Laboratories, figure by figure

Dr. Reddy's Laboratories (RDY) overview: price, valuation and scorecardAll health care companies by market value

Dr. Reddy's Laboratories earnings per share (EPS): questions and answers

What is Dr. Reddy's Laboratories's diluted earnings per share?

Dr. Reddy's Laboratories (RDY) reported diluted earnings per share of ₹51.42 in fiscal 2026 (the year ended March 31, 2026). That is 24.1% lower than the ₹67.79 of fiscal 2025.

What are the highest and lowest diluted earnings per share figures on record for Dr. Reddy's Laboratories?

Across the 4 fiscal years on record (2023–2026), the highest was ₹67.79 in fiscal 2025 and the lowest ₹51.42 in fiscal 2026.

How is Dr. Reddy's Laboratories's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Dr. Reddy's Laboratories (RDY) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/RDY/eps

Underlying data: Yahoo Finance.